Analysis of the data obtained in our study suggests that the increase in the activity of Px in the saliva of BRCA1+ patients with breast cancer indicates an intensified enzymatic antioxidant defence, protecting against oxidative damage to salivary glands and the entire oral cavity. Here, BRCA1 is linked to breast carcinoma.